Medicinal Product Regulation and Product Liability in South Africa
Medicinal product regulation and product liability in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie
A Q&A guide to medicinal product regulation and product liability law in South Africa.
The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.
To read the full Q&A, visit Thomsan Reuters Practical Law.
For information on pharmaceutical patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports, visit Pharmaceutical IP and Competition Law in South Africa: overview.
Used vehicle imports continue to dominate consumer automotive demand
Affordability remains the defining factor in African automotive markets, with used-vehicle imports continuing to dominate demand in countries such as Kenya, Nigeria, and South Africa throughout Februa...
May 14 2026
AfCFTA rules of origin reshape automotive production and trade strategies
Manufacturers operating across Africa are increasingly aligning production strategies with AfCFTA Rules of Origin, which require defined local content thresholds to access tariff benefits across more ...
May 14 2026
EV financing models enable fleet-led adoption in Kenya and South Africa
Financing-led adoption is emerging as the primary driver of EV uptake in African markets, particularly within commercial fleet segments. Operators such as BasiGo in Nairobi are using leasing and pay-a...
May 14 2026